Fairmont Chateau Whistler Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

Antibodies as Drugs (A6)

Scientific Organizers: Pierre Bruhns, Patrick C. Wilson, Esther Breij and David P. Humphreys


January 27—30, 2021

Fairmont Chateau Whistler, Whistler, BC, Canada


Supported by the Directors' Fund


BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

** Registration opens in January 2020 **



Discounted Abstract Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time

Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is )

Global Health Travel Award Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline:

*All deadlines end at 11:59 PM US Mountain Standard Time


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:

  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is )

Discounted Registration Deadline: December 1, 2020

*All deadlines end at 11:59 PM US Mountain Standard Time


Registration Fee: 945.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 720.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1145.00 USD*
Student Registration Fee: 920.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that some meeting participants have received calls and emails from a number of different housing services, including "Exhibitors Housing Services," “Expo Housing Services,” "Global Housing," etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling, without any actual knowledge to that effect, and pressure you into giving them your credit card number to make a lodging reservation with them.

We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report any calls or correspondence you might have received to Keystone Symposia and book only through lodging links in your Keystone Symposia account, an established travel agency or directly with the hotel(s) listed on our website.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Wednesday, January 27 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Saturday, January 30 with a closing plenary session from 14:30 to 19:00, followed by a social hour and entertainment. We recommend return travel on Sunday, January 31 in order to fully experience the meeting.

WEDNESDAY, JANUARY 27

16:00—20:00
Arrival and Registration

18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.


THURSDAY, JANUARY 28

07:00—08:00
Breakfast

08:00—09:00
Welcome and Keynote Address
Registered attendees can view abstracts starting on 12/27/2020

Clive R. Wood†, Boehringer Ingelheim, Germany
Current and Upcoming Challenges in Biologics Development

09:00—11:15
Therapeutic Antibodies from Patients
Registered attendees can view abstracts starting on 12/27/2020

Adrian C. Hayday†, King's College London School of Medicine, UK
Anti-Cytokine Abs from Autoimmune Patients

Coffee Break

Stephen Quake†, Stanford University, USA
Isolation of Rare Human Plasma Cells: Showcasing Anti-Peanut IgE Antibodies

Pauline M. van Helden, AIMM Therapeutics, Netherlands
Mining the B-Cell Repertoire of Cancer Survivors

Short Talks Chosen from Abstracts

11:15—17:00
On Own for Lunch

11:15—13:00
Poster Setup

13:00—22:00
Poster Viewing

14:30—16:30
Workshop

Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

17:00—19:00
Repertoires: Deep Sequencing and Learning
Registered attendees can view abstracts starting on 12/27/2020

Charlotte Deane, University of Oxford, UK
Deep Learning for Antibody Sequences and Antibody Structures

Pierre Bruhns, Institut Pasteur, France
Human Autoimmune Plasma Cell Repertoires

Tineke Cantaert, Institut Pasteur Cambodia, Cambodia
Protective Anti-Dengue Antibody Responses

Short Talks Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

19:30—22:00
Poster Session 1


FRIDAY, JANUARY 29

07:00—08:00
Breakfast

08:00—11:00
Antibodies from Within: Vaccination and Delivery Technologies
Registered attendees can view abstracts starting on 12/27/2020

Patrick C. Wilson, University of Chicago, USA
Understanding Vaccination: The Influenza Model

Peter D. Kwong†, NIAID, National Institutes of Health, USA
Anti-Pathogen/HIV Antibodies

Coffee Break

Nigel Horscroft†, CureVac AG, Germany
mRNA-Based Delivery of Antibody Vaccines

Ronald C. Desrosiers, University of Miami Miller School of Medicine, USA
AAV Delivery of Antibodies for Long-Term Protection

Short Talks Chosen from Abstracts

11:00—17:00
On Own for Lunch

11:00—13:00
Poster Setup

13:00—22:00
Poster Viewing

16:30—17:00
Coffee Available

17:00—19:00
FcRn Exploitation or Targeting
Registered attendees can view abstracts starting on 12/27/2020

David P. Humphreys, UCB Pharma, UK, UK
IgG FcRn Blockade Therapeutics

Els Louagie†, Argenx, Belgium
Clinical Results using Efgartigimog (Argx-113 / AbDeg)

Amita Datta-Mannan, Eli Lilly & Company, USA
FcRn Binding Ab Mutants, Peptide Fusions and Glycan Effects

Short Talks Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

19:30—22:00
Poster Session 2


SATURDAY, JANUARY 30

07:00—08:00
Breakfast

08:00—11:00
The Rise of Bispecifics
Registered attendees can view abstracts starting on 12/27/2020

Aran Frank Labrijn†, Genmab, Netherlands
Overview on Bispecific Technologies and Platforms

Stefan Weigand, F. Hoffmann La Roche AG, Switzerland
Bispecific Antibodies: Case Studies from Roche's R&D Pipeline

Coffee Break

Mark S. Dennis, Denali Therapeutics, USA
BBB Crossing Bispecific Abs

Bruce Keyt†, IGM Biosciences, USA
IgM Bispecifics and Multimers as Therapeutics

Short Talks Chosen from Abstracts

11:00—17:00
On Own for Lunch

14:30—16:30
New Tools
Registered attendees can view abstracts starting on 12/27/2020

Esther Breij, Genmab, Netherlands
Enhanced IgG Hexamerization for Increased Therapeutic Antibody Potency

Brinda Prasad†, Regeneron Pharmaceuticals, USA
Anti-C1q Bispecifics Platform

Aaron K. Sato, Twist Bioscience, USA
High Throughput Synthetic DNA Technologies Enable Antibody Discovery and Optimization

Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

17:00—18:45
Novel Therapeutic Antibodies in the Clinic
Registered attendees can view abstracts starting on 12/27/2020

Cecile Geuijen, Merus NV, Netherlands
The use of Unbiased Screens to Identify Therapeutic Bispecific Antibodies

Eric Vivier, Centre d'Immunologie de Marseille-Luminy, Innate Pharma, France
Exploiting NK Cells to Induce Anti-Tumor Response in Preclinical and Clinical Setting

Neil Brewis†, F-star Biotechnology Ltd., USA
Immuno-Oncology Therapeutics (including OX40x4-1BB Bispecifics)

Short Talks Chosen from Abstracts

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 12/27/2020

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.


SUNDAY, JANUARY 31

 
Departure


*Session Chair †Invited, not yet responded.



We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Corporate Relations, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Nick Dua, Senior Director, Communications, Email: nickd@keystonesymposia.org,
Phone:+1 970-262-1179